High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures.
Ophthalmol Sci
; 2(3): 100188, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36245757
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Ophthalmol Sci
Year:
2022
Document type:
Article
Affiliation country:
Países Bajos